SQZ Biotechnologies PE Ratio 2020-2023 | SQZ
Current and historical p/e ratio for SQZ Biotechnologies (SQZ) from 2020 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. SQZ Biotechnologies PE ratio as of June 09, 2023 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| SQZ Biotechnologies PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2023-06-09 |
0.54 |
|
0.00 |
| 2023-03-31 |
0.56 |
$-2.61 |
0.00 |
| 2022-12-31 |
0.74 |
$-2.76 |
0.00 |
| 2022-09-30 |
2.28 |
$-2.71 |
0.00 |
| 2022-06-30 |
3.18 |
$-2.74 |
0.00 |
| 2022-03-31 |
4.81 |
$-2.64 |
0.00 |
| 2021-12-31 |
8.93 |
$-2.48 |
0.00 |
| 2021-09-30 |
14.42 |
$-2.07 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.016B |
$0.021B |
|
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
|
